The event "Marie Curie Brunch & Briefing – How AI will change the future of cancer" is listed on several calendars.
Please select the one you want to get back to:
Panel discussion, Q&A
Marie Curie Brunch & Briefing – How AI will change the future of cancer
The event will open with welcome remarks by H.E. Laurent Bili, Ambassador of France to the United States, and Rear Admiral Susan Blumenthal, MD (ret), Ambassador, Institut Curie. This dynamic discussion moderated by Mr. Steve Clemons, Contributing Editor, The National Interest, will feature two leading experts: Dr. Sarah Watson, Medical Oncologist and Researcher at Institut Curie, and Dr. Kapil Parakh, Practicing Cardiologist and Senior Medical Lead at Google.
This discussion will illuminate the intersection of clinical oncology, bioinformatics, and technology, illustrating how both Dr. Watson’s and Dr. Parakh’s expertise is advancing the fight against metastases, a critical frontier in cancer research. Following the conversation, attendees will have the opportunity to engage with both speakers during an open Q&A session.
About Institut Curie
Founded by Marie Curie in 1909, Institut Curie is one of the world’s foremost cancer research centers and hospital groups. Its mission to combine scientific discovery with patient care has led to pioneering breakthroughs in cancer treatments, bringing hope to millions of patients worldwide. The Chemical Biology of Cancer Research Center, a key initiative of its U.S. campaign, is set to push the boundaries of cancer research, with a focus on combating metastases and personalizing treatment approaches. The institute aims to raise $3 million in the U.S. as part of the Marie Curie Legacy Initiative through 2025 to support this vital work.